TALZENNA (talazoparib)

SELF ADMINISTRATION - ORAL

Indications for Prior Authorizations: 
  • Indicated in adult patients with deleterious or suspected deleterious germline BReast CAncer susceptibility gene (BRCA)-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative locally-advanced or metastatic breast cancer.
Must meet the following criteria for coverage: 
  • Patient is of 18 years of age or older, AND
  • Prescribed by or in consultation with an oncologist, AND
  • Patient has locally-advanced or metastatic breast cancer, AND
  • Patient has germline BRCA mutation-positive disease, AND
  • Patient has human epidermal growth factor receptor 2 (HER2)-negative breast cancer
Dosing:
  • 1 mg taken orally once daily
  • 0.25 mg capsule is available for dose reduction
Approval: 

1 year

 

Last review date: December 4, 2019

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone